HN
Hansa Bio
HNSA.ST·OMXLund SEFounded 2007200 employees
Small CapbiotechPublicRare DiseaseImmunology
Platform: Idefirix IgG
Market Cap
$0.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (HNSA.ST)
Loading HNSA.ST stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Datocapivasertib | HNS-2249 | Phase 1/2 | 2 | B7-H3 | RSVGBM | ||
| Lisonaritide | HNS-1261 | Preclinical | 2 | CD20 | RAWM |
SEC Filings & Financial Documents
SEC filings are not available for OMX-listed companies.
Hansa Bio trades on OMX (SE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)